Performance

IRD +110.00%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
IRD	+0.48%	+108.96%	+110.00%	-0.33%	-49.22%	1.26	0.00%

Summary

IRD at a glance

IRD returned +110.00% over the past year and -0.33% a year over five years. Its worst drop in that year was -49.22%, smaller than 24% of stocks on Redstone, and its Sharpe ratio of 1.26 beats 85% of stocks on Redstone. It pays no dividends.

Ranking

How IRD ranks

Current Drawdown

-30.81%

Rolling Volatility

79.60%

Actions

Metrics

Risk Indicators

Alpha90.70%

Beta1.20x

Sharpe1.26

Sortino2.17

Omega1.24

Calmar2.23

Martin4.44

Profile

About IRD

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $349M
Listed: Nov 2020
Employees: 28
Headquarters: Durham, NC
Website: opusgtx.com

Comparisons

IRD: Opus Genetics, Inc.

IRD at a glance

How IRD ranks

Current Drawdown

Rolling Volatility

About IRD

Related comparisons